Jonathan David Lanoy Sells 5,000 Shares of Nature’s Sunshine Products (NASDAQ:NATR) Stock

Nature’s Sunshine Products, Inc. (NASDAQ:NATR) CAO Jonathan David Lanoy sold 5,000 shares of the firm’s stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $20.45, for a total transaction of $102,250.00. Following the completion of the transaction, the chief accounting officer directly owned 46,233 shares in the company, valued at approximately $945,464.85. This represents a 9.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Nature’s Sunshine Products Stock Down 4.6%

Shares of NASDAQ:NATR traded down $0.96 during midday trading on Wednesday, hitting $19.86. The stock had a trading volume of 83,154 shares, compared to its average volume of 79,353. The company’s 50-day moving average price is $15.92 and its 200-day moving average price is $15.47. Nature’s Sunshine Products, Inc. has a fifty-two week low of $11.01 and a fifty-two week high of $21.64. The company has a market capitalization of $347.47 million, a P/E ratio of 26.84 and a beta of 1.09.

Nature’s Sunshine Products (NASDAQ:NATR) last announced its quarterly earnings data on Thursday, November 6th. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.18 by $0.18. Nature’s Sunshine Products had a net margin of 3.06% and a return on equity of 10.19%. The business had revenue of $88.99 million for the quarter, compared to analysts’ expectations of $119.39 million. Nature’s Sunshine Products has set its FY 2025 guidance at EPS.

Analyst Ratings Changes

Several brokerages have recently issued reports on NATR. Weiss Ratings reiterated a “hold (c)” rating on shares of Nature’s Sunshine Products in a research note on Wednesday, October 8th. Canaccord Genuity Group raised their price objective on Nature’s Sunshine Products from $21.00 to $22.00 and gave the company a “buy” rating in a research note on Friday, August 1st. Finally, DA Davidson lifted their target price on Nature’s Sunshine Products from $21.00 to $23.00 and gave the company a “buy” rating in a research report on Monday, November 10th. Two investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $22.50.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. AWM Investment Company Inc. acquired a new stake in Nature’s Sunshine Products in the second quarter valued at $5,176,000. Kennedy Capital Management LLC grew its position in shares of Nature’s Sunshine Products by 37.2% in the 2nd quarter. Kennedy Capital Management LLC now owns 589,636 shares of the company’s stock valued at $8,721,000 after buying an additional 160,002 shares during the last quarter. CSM Advisors LLC acquired a new stake in shares of Nature’s Sunshine Products in the second quarter valued at about $1,977,000. Manatuck Hill Partners LLC bought a new position in shares of Nature’s Sunshine Products during the second quarter worth about $1,923,000. Finally, First Eagle Investment Management LLC bought a new position in shares of Nature’s Sunshine Products during the second quarter worth about $1,923,000. Institutional investors and hedge funds own 79.40% of the company’s stock.

About Nature’s Sunshine Products

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.